Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2018, Vol. 14 ›› Issue (06): 740 -744. doi: 10.3877/cma.j.issn.1673-5250.2018.06.019

Special Issue:

Review

Research progress of etiology, diagnosis and treatment of postpartum hemorrhage

Yajuan Wu1, Wei Shan1   

  1. 1. Medical College of Yangzhou University, Yangzhou 225001, Jiangsu Province, China
  • Received:2018-04-09 Revised:2018-10-28 Published:2018-12-01
  • About author:
    Corresponding author: Lu Dan, Email:
  • Supported by:
    Scientific Research Fund of Maternal and Child Health of Jiangsu Provincial Commission of Health and Family Planning(F201663)

Postpartum hemorrhage (PPH) is a serious complication during delivery, and PPH caused by uterine contraction fatigue is the most common kind of PPH. In recent years, the incidence of placenta factors, such as of placenta previa and placenta increta, has been increasing year by year, resulting an increase in the incidence of PPH which can be diagnosed as early as possible via varieties of auxiliary examination means (ultrasound, MRI, cystoscope), to evaluate the pathogenetic conditions and develop individualized therapy strategies, thereby reducing the incidence of PPH. Recent studies on the pathogenesis of PPH suggest that the Universal Two-Child Policy in China and choice of vaginal delivery after cesarean section may increase the incidence of PPH caused by placental factors. For the diagnosis of PPH, the most recent method is not only based on the volume of blood loss during delivery, but also on hemodynamic changes. Currently, the individualized treatment of PPH with strategies of drug therapy, surgical treatment and interventional therapy have achieved good clinical efficacy. The article focuses on the latest advances in etiology, diagnosis and treatment of PPH.

[1]
谢幸, 苟文丽. 妇产科学[M]. 8版. 北京:人民卫生出版,2013: 211-215 .
[2]
陆红梅,张卫社. 产妇产后出血影响因素调查及综合护理对策[J]. 中国现代医生,2013, 51(33): 47-49.
[3]
Mavrides E, Allard S, Chandraharan E, et al. Royal College of Physicians: prevention and management of postpartum hemorrhage[J]. Br J Obstet Gynaecol, 2017, 124(5): e106-e149.
[4]
Committee on Practice Bulletins-Obstetrics. Practice bulletins No.183: postpartum hemorrhage[J]. Obstet Gynecol, 2017, 130(4): e168-e186.
[5]
李春凤. 产后出血的相关因素及治疗进展[J]. 医学信息,2015, 28(19): 358.
[6]
Talaulikar VS, Arulkumaran S. Vaginal birth after cesarean[J]. Obstet Gynecol Reprod Med, 2015, 25(7): 195-202.
[7]
吕斌,陈锰,刘兴会. 前置胎盘孕妇围产期行子宫切除术的危险因素分析[J].中华妇产科杂志,2016, 51(7): 498-502.
[8]
de la Cruz CZ, Thompson EL, O′Rourke K, et al. Cesarean section and the risk of emergency peripartum hysterectomy in high-income countries: a systematic review[J]. Arch Gynecol Obstet, 2015, 292(6): 1201-1215.
[9]
陈东. 产后出血及其临床救治探析[J]. 大家健康(学术版), 2015, 9(20): 191.
[10]
Winikoff B, Dabash R, Durocher J, et al Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial[J]. Lancet, 2010, 375(9710): 210-216.
[11]
朱恢玫. 催产素与米索前列醇治疗产后出血的临床效果评价[J]. 临床医学研究与实践,2016, 1(21): 17-19.
[12]
刘兴会,张力,张静. 《产后出血预防与处理指南(草案)》(2009)及《产后出血预防与处理指南(2014年版)》解读[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(4): 433-447.
[13]
Jin B, Du YM, Zhang FB, et al. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and Meta-analysis of randomized controlled trials [J]. J Matern Fetal Neonatal Med, 2016, 29(3): 400-407.
[14]
曾成英,万波,郭遂群,等. Bakri球囊填塞与B-Lynch缝合治疗剖宫产术后产后出血的疗效比较[J]. 实用妇产科杂志,2016, 32(6): 472-474.
[15]
韦献琼,马刚. 子宫收缩乏力性产后出血的病因及治疗进展[J]. 中国临床新医学,2010, 3(11): 1148-1150.
[16]
同芙菊,郭丹凤,李悦,等. 产后出血的治疗研究进展[J]. 中国妇幼保健,2017, 32(6): 1336-1338.
[17]
梁媚珍,唐莉,文思敏,等. 凶险型前置胎盘诊治进展[J]. 中国医学创新,2015, 12(12): 153-156.
[18]
朱晓童,孔祥,郑英. 介入治疗在前置胎盘合并胎盘植入剖宫产分娩中应用的研究进展[J/CD] . 中华妇幼临床医学杂志(电子版), 2017, 13(2): 240-243.
[19]
王利民,罗丹,周辉,等. 动脉序贯介入治疗对凶险型前置胎盘的疗效评价[J]. 现代妇产科进展,2015, 24(11): 823-827.
[20]
Woman Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN) : an international, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2017, 389(10084): 2105-2116.
[21]
Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accrete[J]. Obstet Gynecol, 2015, 126(3): 654-668.
[22]
D′Arpe S, Franceschetti S, Corosu R, et al. Emergency peripartum hysterectomy in a tertiary teaching hospital: a 14-year review[J]. Arch Gynecol Obstet, 2015, 291(4): 841-847.
[23]
Temizkan O, Ang1n D, Karaku R, et al. Changing trends in emergency peripartum hysterectomy in a tertiary obstetric center in Turkey during 2000-2013[J]. J Turk Ger Gynecol Assoc, 2016, 17(1): 26-34.
[24]
Rac MW, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the placenta accreta index[J]. Am J Obstet Gynecol, 2015, 212(3): 343. e1-e7.
[25]
Aitken K, Allen L, Pantazi S, et al. MRI significantly improves disease staging to direct surgical planning for abnormal invasive placentation: a single centre experience[J]. J Obstet Gynaecol Can, 2016, 38(3): 246-251. e1.
[26]
Main EK, Goffman D, Seavone BM, et al. National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage[J]. Obstet Gynecol, 2015, 126(1): 155-162.
[1] Shuqin Zhang, Lian Chen. Diagnosis and treatment of postpartum intrauterine retained products of conception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 493-497.
[2] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[3] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[4] Mengling Zhou, Zhiwei Xue, Shu Zhou. Changes in size of uterine myoma during pregnancy and its association with adverse pregnancy outcomes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 611-615.
[5] Fan Hong, Dunjin Chen, Yang Fu, Xinyue Liang, Yi Wu, Xiaoyi Wang. Clinical study of in vitro fertilization-embryo transfer pregnancy complicated with placenta previa[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(03): 176-182.
[6] Miao Hu, Lili Du, Lizi Zhang, Lin Lin, Yuliang Zhang, Shifeng Gu, Zhongjia Gu, Siying Lai, Jingying Liang, Yu Liu, Minshan Huang, Yuanyuan Huang, Qingqing Huang, Shijun Luo, Dunjin Chen. A study on placenta accreta grading and perinatal outcomes in patients conceived through in vitro fertilization/intracytoplasmic sperm injection[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(03): 183-189.
[7] Ting Li, Yincheng Teng. In vitro fertilization-embryo transfer and placenta previa[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2024, 13(02): 84-87.
[8] Xianqin Yin, Yuyin Liu, Lili Mao, Wen Sun, Dunjin Chen. Effect of timing of previous cesarean section on clinical outcomes of second pregnancy with placenta previa.[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(04): 244-248.
[9] Yongfei Yue, Liping Zhu, Xiaoyan Wang. Evaluation of blood loss by magnetic resonance imaging during cesarean section in placenta accreta spectrum disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 167-172.
[10] Shifeng Gu, Lizi Zhang, Jingying Liang, Lili Du, Wen Sun, Dunjin Chen. Hot spots of placenta accreta spectrum disorders research in China from 2011 to 2021: a visualized analysis based on CiteSpace[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 159-166.
[11] Lizi Zhang, Dunjin Chen. Adverse outcomes and long­term prognosis of placenta accreta spectrum disorders[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 155-158.
[12] Zhirong Guo, Jingmei Ma. Risk factors assessment and surgical strategies of placenta accreta spectrum[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 151-154.
[13] Yong Wang, Xialin Li, Rong Yang, Kangni Pan, Lin Yu, Weiwei Wang, Wen Sun, Dunjin Chen. A study of transfusion protocol in placenta accreta complicated with severe postpartum hemorrhage[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 173-179.
[14] Guanghua Liu, Qiang Ouyang, Juming Yu, Guoping Fan, Jingmin Ou, Mingke Qiu, Feikai Lin, Huizhen Sun, Hui Zhang, Xipeng Wang, Minfei Jin. Clinical application of caesarean section assisted by bilateral internal iliac artery balloon occlusion with sequential uterine artery embolization[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(01): 33-38.
[15] Haoran Cui, Junpeng Gu, Weixin Ren. Progress in the treatment of liver cancer with portal vein thrombosis based on TACE[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(01): 64-69.
Viewed
Full text


Abstract